The race to increase human life span through biotech just ... s disease treatment that’s set to enter an early-stage trial in ...

OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...

SoftBank is in talks to invest as much as $25bn into OpenAI. The deal would make it the start-up’s biggest financial backer.

ChatGPT 5 release date is expected in early 2025, bringing advanced features like better conversations and multimodal support ...

OpenAI has demoed the AI agent browsing the web just like a human would, with the ability to interact with websites and ...

Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite swirling rumours about a potential launch, some fuelled by his own ...

According to a Bloomberg report, Ann Altman, 30, alleged that Sam Altman abused and manipulated her while they were growing up in Missouri in the late 1990s to early 2000s. The report said the ...

propelling the market for life-extending therapeutics into a $25 billion business. OpenAI CEO Sam Altman (left), Amazon’s Jeff Bezos (center), and PayPal cofounder Peter Thiel (right ...

spanning the late 1990s to early 2000s. The lawsuit, filed on Monday, asserts that the abuse began when she was just three years old, with the last alleged incident occurring when Sam Altman was ...